PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

Abstract: we have performed the first-ever comparative pharmacoeconomic analysis in a Russian context of bendamustine in the first line of therapy of a multiple myeloma for for patients more senior 65 years old with clinical manifestations of a polineuropathy, which autological transplantation of st...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Format: Article
Language:Russian
Published: IRBIS LLC 2015-03-01
Series:Фармакоэкономика
Subjects:
multiple myeloma
bendamustine
pharmacoeconomics
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/64
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items